If clinically appropriate, the practitioner would issue a prescription for the medication. The medical practitioner is responsible for consultation and any diagnostic tests to determine that a patient has a parasitic infection that fits within the guideline-recommended uses for ivermectin treatment.The process for prior authorization and prescriptions is as follows: Ivermectin is generally safe to use when prescribed appropriately. Taking large, or potentially unknown, doses of ivermectin can be dangerous. Ivermectin is not covered for treatment of COVID-19 by any UnitedHealthcare plan. Most approved indications for ivermectin are treated with 1 or 2 doses of oral (human) ivermectin and should be within the allowed quantity of 20 tablets within 90 days. Coverage for prescription claims of ivermectin for treatment outside of approved indications and guideline-recommended uses will be denied.įor approved indications and guideline-recommended uses, UnitedHealthcare criteria allows a limit of 20 ivermectin tablets prescribed within 90 days. 1 Coverage of ivermectin is dependent upon specific health plan certificates of coverage. Ivermectin tablets are approved by the FDA only for the medical treatment of specific parasitic infections in humans. 15, 2021 – Medicare Advantage, Medicaid and Individual Exchange plans 10, 2021 – Individual and Group Market health plans The prior authorization and supply limits are effective beginning as follows:
![authorizations made easy authorizations made easy](https://2-control.nl/media/1639/quickscan-autorisaties-20190813-listing.jpg)
![authorizations made easy authorizations made easy](https://www.accessinformer.com/wp-content/uploads/2020/08/slide_jti2.jpg)
This is to help ensure ivermectin is only prescribed in appropriate doses for approved indications and guideline-recommended uses. UnitedHealthcare has implemented prior authorization and supply limits on the oral dosage form of ivermectin (human formulation).